Cipla Limited (BOM:500087)
India · Delayed Price · Currency is INR 1,232.90
+4.00 (0.33%)
At close: Apr 21, 2026
Cipla Market Cap
Cipla has a market cap or net worth of 995.59 billion as of April 21, 2026. Its market cap has decreased by -16.49% in one year.
Market Cap
995.59B
Enterprise Value
895.30B
Revenue
279.67B
Ranking
n/a
PE Ratio
21.90
Stock Price
1,232.90
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 995.59B, an increase of 65,672.00%. That is a compound annual growth rate of 24.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 993.17B | -18.65% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.87% |
| Dec 30, 2022 | 868.37B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.42T |
| Lupin | 1.06T |
| Dr. Reddy's Laboratories | 1.03T |
| Abbott India | 548.17B |
| GlaxoSmithKline Pharmaceuticals | 412.01B |
| J. B. Chemicals & Pharmaceuticals | 320.69B |
| AstraZeneca Pharma India | 213.00B |
| Granules India | 164.48B |